Illuminate the Path to a Brighter Future for Lupus Research in SLE trials
The disease assessments that are being used in lupus SLE studies are very sensitive to small changes. Data variability can obscure the ability to detect disease activity changes, improvement, or worsening. Unlike a lot of studies, the precision of the data really matters here. These are the challenges that we had in mind we set out to use the direct data capture technology that Clinical Ink has been using for years and apply it to a specific therapeutic area, in this case, Lupus SLE.